7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 
      
    		                                         
      operating activities
    		                                         
      net income
    		-16,231,000 -19,657,000 -18,146,000 -33,580,000 -21,409,000 -50,545,000 -40,838,000 -36,779,000 -30,444,000 -32,812,000 -34,626,000 -31,460,000 -27,576,000 -45,536,000 5,377,000 -21,872,000 6,230,000 -17,482,000 -16,469,000 -10,648,000 -15,748,000 -39,894,000 -54,058,000 36,581,000 -13,506,000 -6,309,000 -1,342,000 1,779,000 -6,621,000 -5,398,000 -2,711,000  1,325,000 -3,301,000 878,000  1,159,000 2,332,000 897,000 -2,290,000 -2,057,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                                         
      depreciation
    		2,777,000 2,725,000 2,651,000 2,768,000 2,743,000 2,753,000 2,685,000 2,287,000 2,226,000 2,151,000 2,078,000 1,954,000 1,666,000 1,662,000 1,382,000  1,162,000 1,163,000 1,150,000                       
      amortization of intangible assets
    		6,356,000 5,844,000 5,576,000 5,972,000 6,256,000 6,245,000 6,228,000 6,228,000 6,228,000 6,228,000 6,228,000 6,228,000 6,228,000 6,228,000 6,228,000  6,228,000 6,228,000 6,228,000                       
      amortization of right-of-use lease assets
    		1,055,000 1,055,000 1,078,000                                       
      amortization of debt issuance costs
    		   56,000 67,000 252,000 343,000 343,000 343,000 344,000 343,000 343,000 343,000 344,000 343,000 343,000 343,000 344,000 343,000                       
      deferred income tax benefit
    		11,000 -8,000 -10,000 -215,000 1,000   -105,000 -9,000 -1,000 -5,000 -37,000 -5,000 -6,000 -6,000 -957,000 -24,000 -24,000 -24,000 -2,836,000 -1,086,000 -7,545,000 -709,000                   
      loss on disposal of fixed assets
    		20,000 5,000 6,000  0               80,000 272,000   404,000 19,000   73,000 5,000 77,000 1,000  0         
      stock-based compensation
    		14,913,000 18,019,000 12,986,000 13,309,000 14,420,000 11,313,000 11,165,000 12,987,000 10,484,000 9,873,000 10,184,000 11,688,000 9,411,000 10,539,000 6,923,000 7,225,000 6,189,000 7,984,000 8,748,000 8,744,000 9,660,000 10,897,000 17,176,000 12,470,000 8,547,000 8,247,000 7,129,000 6,668,000 7,173,000 6,461,000 5,402,000  4,718,000 4,733,000 3,202,000  2,652,000 2,048,000 1,417,000 1,558,000 1,552,000 
      unrealized foreign currency (gain) loss
    		                                         
      amortization of premium on short-term investments
    		-498,000 -1,050,000 -1,149,000  -962,000 -1,114,000 -1,111,000  -699,000 -287,000 -55,000 130,000 159,000 206,000 236,000                -58,000  -3,000 31,000 27,000  45,000 79,000 82,000   
      other liabilities
    		313,000 1,906,000 -1,091,000 312,000 1,398,000 970,000 2,526,000 818,000 -122,000 1,669,000 684,000   118,000 -163,000 514,000 400,000 981,000 570,000  1,019,000 2,117,000 207,000                   
      acquired in-process r&d acquired through the issuance of common stock
    		   0 0 0 5,000,000 0 0                                 
      inducement expense related to exchange of convertible senior notes
    		   0 0                                     
      allowance for doubtful accounts
    		3,002,000 2,700,000 1,367,000                                       
      changes in operating assets and liabilities:
    		                                         
      accounts receivable
    		-18,792,000 -11,668,000 -12,316,000 -5,490,000 -4,462,000 -4,908,000 -7,106,000 -308,000 -435,000 -1,449,000 -1,651,000 -17,000 175,000 -1,873,000 -1,423,000 1,206,000 2,173,000 -1,132,000 -547,000 -3,386,000 -5,927,000 2,310,000 9,246,000 -804,000 -2,475,000 -1,394,000 -1,959,000 957,000 -2,565,000 219,000 -863,000  -194,000 -2,208,000 -81,000  -119,000 -2,069,000 -1,982,000 -575,000 -476,000 
      inventory
    		659,000 -2,731,000 -1,668,000 -627,000 -3,056,000 -6,554,000 -8,551,000 -1,927,000 -620,000 806,000 -3,089,000 -3,591,000 -6,730,000 -3,401,000 -1,750,000 -3,446,000 -2,394,000 -2,266,000 403,000 -20,616,000 1,182,000 6,828,000 14,568,000 3,664,000 1,166,000 -595,000 -157,000 208,000 215,000 -1,236,000 -1,490,000  -550,000 -830,000 -538,000  -612,000 -450,000 -1,129,000 -948,000 -243,000 
      prepaid expenses and other current assets
    		-4,852,000 1,420,000 -2,339,000 3,652,000 -3,971,000 4,565,000 -912,000 1,470,000 -887,000 1,030,000 -2,498,000 1,635,000 -2,753,000 67,000 -669,000 1,985,000 -1,281,000 -1,955,000 -1,803,000 -704,000 -2,723,000 629,000 -2,235,000 1,409,000 -2,788,000 635,000 -173,000 -61,000 106,000 -1,093,000 -708,000  -153,000 243,000 478,000  -1,265,000 224,000 -355,000 -7,000 -581,000 
      accounts payable and accrued liabilities
    		7,799,000 6,616,000 -6,729,000 4,427,000 565,000 -1,351,000 -3,620,000 7,454,000 3,376,000 -259,000 -9,266,000 9,057,000 -10,214,000 15,945,000 -7,578,000 782,000 -3,658,000 12,301,000 3,023,000 3,458,000 -8,139,000 6,748,000 -4,750,000 839,000 1,951,000 3,123,000 -5,134,000 4,527,000 4,149,000 1,907,000 -8,056,000  629,000 4,461,000 -2,316,000  968,000 2,844,000 -816,000 356,000 -25,000 
      deposits and other assets
    		-472,000 -683,000 -134,000                                       
      net cash from operating activities
    		-10,090,000 6,979,000 -18,521,000 507,000 -9,586,000 -18,369,000 -33,870,000 -10,665,000 -8,168,000 -8,161,000 -30,764,000 -4,136,000 -26,515,000 -12,206,000 9,774,000 -4,651,000 17,790,000 7,391,000 4,178,000 10,604,000 -9,570,000 -10,923,000 -13,099,000 -4,191,000 -2,988,000 6,602,000 208,000 17,128,000 4,362,000 4,012,000 -6,638,000  6,991,000 4,262,000 2,376,000  3,929,000 6,039,000 -937,000 -570,000 -557,000 
      capex
    		-1,387,000 -1,091,000 -1,436,000 -938,000 -1,848,000 -3,212,000 607,000 -6,082,000 -3,239,000 -5,107,000 -4,487,000 -7,682,000 -6,091,000 -8,796,000 -3,899,000 -9,327,000 -9,916,000 -11,360,000 -17,182,000 -2,145,000 -1,281,000 -2,727,000 -782,000 -1,194,000 -1,007,000 -1,872,000 -651,000 -7,582,000 -727,000 -760,000 -1,246,000  -2,382,000 -1,311,000 -760,000  -3,017,000 -842,000 -377,000 -375,000 -183,000 
      free cash flows
    		-11,477,000 5,888,000 -19,957,000 -431,000 -11,434,000 -21,581,000 -33,263,000 -16,747,000 -11,407,000 -13,268,000 -35,251,000 -11,818,000 -32,606,000 -21,002,000 5,875,000 -13,978,000 7,874,000 -3,969,000 -13,004,000 8,459,000 -10,851,000 -13,650,000 -13,881,000 -5,385,000 -3,995,000 4,730,000 -443,000 9,546,000 3,635,000 3,252,000 -7,884,000  4,609,000 2,951,000 1,616,000  912,000 5,197,000 -1,314,000 -945,000 -740,000 
      investing activities
    		                                         
      cash paid for acquisitions, net of cash acquired
    		0                                         
      purchase of real estate property
    		0                                         
      purchases of short-term investments
    		-75,366,000 -42,022,000 -74,743,000 -66,864,000 -32,002,000 -41,839,000 -49,250,000 -72,049,000 -23,468,000 -73,775,000 -96,295,000 -12,000,000 -10,318,000 -20,191,000 -16,747,000 -23,529,000 -94,523,000 -43,226,000 -54,007,000 -27,204,000 -212,915,000 -42,203,000 -18,680,000 -15,662,000 -23,868,000 -24,245,000 -16,613,000 -23,596,000 -22,968,000 -19,213,000 -27,919,000  -25,671,000 -19,167,000 -26,599,000  -24,899,000 -12,115,000 -23,710,000   
      proceeds from sales and maturities of short-term investments
    		74,543,000 53,533,000 40,878,000 80,308,000 65,161,000 79,850,000 21,880,000 64,365,000 41,822,000 107,011,000 89,902,000 37,663,000 40,746,000 39,564,000 17,184,000 24,560,000 78,664,000 53,343,000 50,349,000 26,613,000 33,073,000 25,335,000 19,676,000 18,624,000 20,801,000 24,880,000 16,189,000 14,666,000 17,763,000 22,325,000 24,097,000  26,610,000 19,323,000 25,257,000  17,748,000 8,354,000 15,600,000   
      purchases of property and equipment
    		-1,635,000 -1,179,000 -1,938,000 -1,733,000 -1,450,000 -2,149,000 -968,000 -4,214,000 -3,360,000 -5,766,000 -6,908,000 -8,221,000 -6,039,000 -9,401,000 -6,604,000 -9,327,000 -9,916,000 -11,360,000 -17,182,000 -2,145,000 -1,281,000 -2,727,000 -782,000 -1,194,000 -1,007,000 -1,872,000 -651,000 -7,582,000 -727,000 -760,000 -1,246,000  -2,382,000 -1,311,000 -760,000  -3,017,000 -842,000 -377,000 -375,000 -183,000 
      proceeds from disposal of property and equipment
    		   0 0       55,000 0 41,000 55,000 0 0                         
      investment in company-owned life insurance
    		-1,535,000 -2,070,000 -395,000 76,000 -1,146,000 -1,036,000 -1,045,000 -1,023,000 -97,000 -1,519,000 -531,000 -842,000 2,000 -383,000 215,000 -576,000 -288,000 -794,000 -423,000 -723,000 -439,000 -1,072,000 414,000    -638,000               
      other investing activities
    		0 0 -750,000                                       
      net cash from investing activities
    		-3,993,000 -20,782,000 -36,948,000 11,787,000 30,563,000 34,864,000 -29,383,000 -12,921,000 14,897,000 25,951,000 -13,832,000 16,655,000 24,391,000 9,630,000 -5,897,000 -8,872,000 -26,063,000 -2,034,000 -21,263,000  -181,562,000 -20,667,000 628,000  -4,074,000 -599,000 -1,713,000 -17,752,000 -5,932,000 2,352,000 -5,068,000  -1,443,000 -1,155,000 -2,102,000  -10,168,000 -4,603,000 -8,487,000 -70,126,000 -183,000 
      financing activities
    		                                         
      proceeds from exercise of stock options
    		1,483,000 4,972,000 4,082,000 9,838,000 5,509,000 10,945,000 13,055,000 6,124,000 4,310,000 1,639,000 675,000 706,000 950,000 1,373,000 548,000 1,741,000 1,559,000 6,272,000 16,552,000 9,938,000 3,668,000 2,136,000 4,454,000 1,059,000 4,834,000 4,564,000 4,607,000 2,236,000 11,812,000 3,154,000 1,452,000  484,000 812,000 1,970,000  1,335,000 1,976,000 438,000 15,000 355,000 
      proceeds from share purchases under employee stock purchase plan
    		4,725,000 0 2,961,000  4,729,000 0 2,687,000  4,115,000 0 2,163,000  3,845,000 0 1,785,000  3,268,000 0 1,549,000  2,747,000 0 1,278,000  2,486,000                 
      payment of employee taxes related to vested restricted stock units
    		-649,000 -2,449,000 -4,845,000  -328,000 -2,127,000 -2,378,000  -768,000 -2,341,000 -1,537,000  -445,000 -1,136,000 -818,000  -858,000 -1,747,000 -1,065,000  -594,000 -501,000 -1,512,000  -654,000 -4,246,000 -102,000  -7,000             
      principal paid on finance lease
    		-295,000 -278,000 -248,000 -212,000 -242,000 -226,000 -197,000 -194,000 -190,000 -178,000 -149,000 -147,000 -144,000 -131,000 -105,000 -104,000 -102,000 -202,000 -251,000                       
      net cash from financing activities
    		5,264,000 2,245,000 1,950,000 60,113,000 9,668,000 8,592,000 13,167,000 7,303,000 7,467,000 -880,000 1,152,000 529,000 4,206,000 106,000 1,410,000 1,617,000 3,867,000 16,362,000 17,414,000 8,659,000 5,821,000 243,842,000 4,220,000 -22,036,000 6,666,000 318,000 5,407,000 1,974,000 13,926,000 2,836,000 2,840,000  484,000 1,780,000 1,970,000  -911,000 550,000 -1,703,000 -988,000 -10,075,000 
      effect of exchange rate changes on cash and cash equivalents
    		6,252,000 -2,780,000 -1,855,000 -2,924,000 1,423,000 -630,000 -886,000 821,000 -79,000 282,000 317,000 459,000 -667,000 -1,467,000 207,000 -517,000 -759,000 -48,000 -450,000 38,000 -669,000 1,108,000 -565,000 -244,000 -29,000   -32,000 -19,000 154,000 -55,000  -84,000 -138,000 -117,000  -201,000 -39,000 -53,000 -83,000 10,000 
      net increase in cash, cash equivalents and restricted cash
    		   69,483,000    -15,462,000 14,117,000 17,192,000 -43,127,000 13,507,000 1,415,000 -3,937,000 5,494,000 -12,423,000    15,842,000 -185,980,000 213,360,000 -8,816,000 23,341,000 -425,000 6,347,000 3,897,000 1,318,000 12,337,000 9,354,000 -8,921,000           
      cash, cash equivalents and restricted cash at beginning of period
    		0 0 174,359,000 0 0 0 99,323,000 0 0 0 126,603,000 0 0 0 110,124,000 0 0 0 106,162,000 0 0 0 71,756,000 0 0 0 38,596,000 0 0 0 24,508,000           
      cash, cash equivalents and restricted cash at end of period
    		-2,567,000 -14,338,000 118,985,000 69,483,000 32,068,000 24,457,000 48,351,000 -15,462,000 14,117,000 17,192,000 83,476,000 13,507,000 1,415,000 -3,937,000 115,618,000 -12,423,000 -5,165,000 21,671,000 106,041,000 15,842,000 -185,980,000 213,360,000 62,940,000 23,341,000 -425,000 6,347,000 42,493,000 1,318,000 12,337,000 9,354,000 15,587,000           
      supplemental disclosures of cash flow information
    		                                         
      taxes paid, net of refunds
    		173,000 235,000 276,000 195,000 364,000 450,000 351,000 339,000 438,000 525,000 255,000                               
      interest paid on convertible senior notes
    		   791,000 0   3,953,000 0   3,953,000                              
      other interest paid
    		1,049,000 1,057,000 1,058,000 1,073,000 1,077,000 1,243,000 1,073,000 1,111,000 1,076,000   1,084,000 1,159,000 1,100,000 1,091,000                           
      supplemental schedule of noncash investing and financing activities
    		                                         
      contingent consideration acquired
    		0                                         
      convertible senior notes exchanged for common stock, net of debt issuance costs
    		   0                                      
      purchases of property and equipment included in accounts payable and accrued liabilities
    		248,000 88,000 502,000 795,000 -398,000 -1,063,000 1,575,000 -1,868,000 121,000 659,000 2,421,000 539,000 -52,000 605,000 2,705,000                           
      unrealized foreign currency losses
    		 2,486,000 1,397,000 4,130,000 -2,421,000 1,455,000 1,456,000  894,000 283,000 -186,000 -1,977,000 1,950,000   477,000 1,009,000 -274,000 1,101,000    2,024,000 -275,000   87,000 106,000 356,000             
      net decrease in cash, cash equivalents and restricted cash
    		 -14,338,000 -55,374,000   24,457,000 -50,972,000           21,671,000 -121,000                       
      ​
    		                                         
      gain on disposal of fixed assets
    		      10,000 12,000     64,000 10,000 -45,000                           
      (amortization of premium) accretion of discount on short-term investments
    		                                         
      loss on capped call transaction
    		                                         
      inventory write-down
    		                                         
      other assets
    		   -67,000 183,000 25,000 -2,216,000 -1,636,000 -421,000 118,000 59,000 187,000 -360,000 62,000 -217,000 84,000 -73,000 146,000 29,000 69,000 429,000 -212,000 1,000 -1,691,000 -29,000 5,000 -62,000 1,332,000 -229,000 -739,000 -160,000  -209,000 -205,000 -163,000     -7,000 -10,000 
      proceeds from partial unwinding of capped calls related to issuance of convertible senior notes
    		                                         
      share purchases under employee stock purchase plan
    		                          902,000 0 2,121,000 0 1,388,000  0    0     
      payments of employee taxes related to vested restricted stock units
    		                                         
      payments related to convertible senior notes
    		                                         
      payments related to capped call transactions
    		                                         
      issuance of common stock related to conversion of convertible senior notes, net of debt issuance costs
    		                                         
      noncash lease expense
    		    1,062,000 1,061,000 1,071,000  1,037,000                                 
      convertible notes exchanged for common stock, net of debt issuance costs
    		                                         
      adjustments to reconcile net income to net cash (used in) provided operating activities:
    		                                         
      unrealized foreign currency (gains) losses
    		              -135,000                           
      (accretion of discount) amortization of premium on short-term investments
    		                                         
      proceeds from tenant improvement allowance
    		               0 0 12,039,000 629,000                       
      amortization of lease right-of-use assets
    		          1,036,000  1,082,000 1,025,000 1,271,000  1,232,000 1,117,000 1,170,000  1,259,000 1,266,000 1,311,000  1,009,000                 
      interest paid
    		          1,086,000                          56,000 85,000 112,000 140,000 195,000 
      amortization of the fair market value inventory adjustment
    		                                         
      amortization of debt discount
    		                                         
      (gain) loss on disposal of fixed assets
    		                                         
      change in fair value of cash-settled stock options
    		                                         
      proceeds from convertible senior notes
    		                   0 0                     
      payment of convertible senior notes transaction costs
    		                   0 0                     
      purchase of capped calls related to issuance of convertible senior notes
    		                   0 0                     
      taxes paid
    		            132,000 149,000 91,000  87,000    124,000 44,000 250,000  5,000 51,000 40,000  -352,000 362,000 3,000  0 63,000 1,000  1,000 1,000 62,000 11,000 3,000 
      depreciation and amortization
    		                   7,400,000 7,337,000 7,334,000 7,310,000 3,632,000 946,000 886,000 842,000 1,201,000 1,702,000 1,696,000 1,665,000  1,513,000 1,419,000 1,009,000  1,155,000 1,133,000 1,122,000 1,068,000 1,056,000 
      amortization of the fair market value inventory adjustment as a result of the avedro merger
    		                                         
      amortization of premium (discount) on short-term investments
    		                 260,000 256,000                       
      cash acquired due to acquisition
    		                                         
      payment of debt assumed in the avedro merger
    		                                         
      shares issued, and replacement awards assumed, in connection with avedro merger
    		                                         
      debt assumed in the avedro merger
    		                                         
      change in fair value of cash settled stock options
    		                    0 -1,000 -3,171,000                   
      taxes (refunded) paid
    		                  -35,000                       
      amortization of debt discount and deferred financing costs
    		                                       0 0 
      deferred rent and other liabilities
    		                       1,686,000 1,576,000 1,401,000 689,000 428,000              
      net cash (used) provided by investing activities
    		                                         
      amortization of debt discount and issuance costs
    		                    2,677,000                     
      amortization of discount on short-term investments
    		                    196,000 52,000 -19,000  -77,000 -109,000 -112,000               
      fair value of cash-settled stock options
    		                                         
      amortization of (discount) premium on short-term investments
    		                           -90,000 -70,000             
      deferred tax asset and receivable
    		                                         
      net cash from (used) in investing activities
    		                                         
      reduction of liability upon vesting of stock options previously exercised for unvested stock
    		                                1,000 0 3,000  12,000 21,000 21,000 21,000 21,000 
      amortization of operating lease right-of-use asset
    		                          400,000               
      change in fair value of stock warrant liability
    		                                    0 0 -43,000 2,000 -31,000 
      payments of subordinated notes
    		                                       -2,164,000 -2,137,000 
      proceeds from exercise of stock warrants
    		                                    0   0 50,000 
      restricted cash
    		                                0 31,000 49,000       
      deferred rent
    		                             511,000 839,000  239,000 165,000 173,000   -17,000 19,000 30,000 72,000 
      unrealized foreign currency gains
    		                              -499,000  -324,000 -282,000 -342,000       
      net cash provided by:
    		                                         
      exchange rate changes
    		                                         
      net increase in cash and cash equivalents
    		                               5,176,000 5,948,000 4,749,000 2,127,000 1,484,000 -7,351,000 1,947,000 -11,180,000 -71,767,000 -10,805,000 
      payments of secured notes
    		                                    -2,246,000 -2,219,000 -2,191,000   
      cash and cash equivalents at beginning of period
    		                                0 0 6,494,000  0 0 21,572,000 0 0 
      cash and cash equivalents at end of period
    		                                5,948,000 4,749,000 8,621,000  -7,351,000 1,947,000 10,392,000 -71,767,000 -10,805,000 
      loss on deconsolidation of dose
    		                                       0 0 
      loss on extinguishment of debt
    		                                       0  
      purchase of idose product line and related assets from dose medical
    		                                       0 0 
      proceeds from public offering, net of issuance costs
    		                                         
      proceeds from senior secured term and draw-to term loans
    		                                       0  
      payments of senior secured term and draw-to term loans
    		                                       0  
      payments of line of credit
    		                                         
      unrealized gains on intercompany loans
    		                                     -80,000 -149,000   
      proceeds from exercise of stock warrant
    		                                      50,000   
      unrealized losses on intercompany loans
    		                                         
      accrued interest expense
    		                                         
      proceeds from line of credit
    		                                         
      proceeds from issuance of series f preferred stock
    		                                         
      payment to acquire treasury stock
    		                                         
      purchase of intangible asset in exchange for issuance of subordinated note
    		                                         
      purchase of intangible assets in exchange for future payments
    		                                         
      conversion of convertible notes and accrued interest into series f convertible preferred stock
    		                                         
      conversion of preferred stock into common stock
    		                                         
      proceeds from initial public offering, net of issuance costs
    		                                        -1,343,000 
      net payments of revolving line of credit
    		                                        0 
      net proceeds from senior secured term and draw-to term loans
    		                                         
      issuance costs associated with initial public offering in accounts payable and accrued liabilities
    		                                         
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.